Literature DB >> 14743655

Pediatric brain tumors.

Nicole J Ullrich1, Scott L Pomeroy.   

Abstract

Brain tumors in children vary with regard to histology, location, gender distribution, and age of onset. The past several decades have witnessed substantial improvements in the diagnosis and treatment. As a result, the number of long-term survivors also has increased continuously. Recent advances in neuroimaging facilitate tumor localization and mapping of brain function by noninvasive techniques and are becoming important in preoperative assessment for brain tumors. Surgery remains the mainstay of treatment of many tumor types. A role for chemotherapy is emerging, particularly for nonresectable tumors and in infants, for whom the adverse effects of radiation therapy are severe. Despite the improved treatments and prognostic data, however, many long-term survivors experience significant neurocognitive and developmental deficits.

Entities:  

Mesh:

Year:  2003        PMID: 14743655     DOI: 10.1016/s0733-8619(03)00014-8

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  11 in total

Review 1.  Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.

Authors:  Linfeng Wu; Xiaoxun Li; Dileep R Janagam; Tao L Lowe
Journal:  Pharm Res       Date:  2013-08-31       Impact factor: 4.200

Review 2.  Pediatric surgical neuro-oncology: current best care practices and strategies.

Authors:  James T Rutka; John S Kuo
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

3.  Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.

Authors:  Cesare Colosimo; Philippe Demaerel; Paolo Tortori-Donati; Catherine Christophe; Mark Van Buchem; Barry Högström; Gianpaolo Pirovano; Ningyan Shen; Miles A Kirchin; Alberto Spinazzi
Journal:  Pediatr Radiol       Date:  2005-01-28

4.  Leukotriene Synthesis Is Critical for Medulloblastoma Progression.

Authors:  Fang Du; Larra Yuelling; Eric H Lee; Yuan Wang; Shengyou Liao; Yan Cheng; Li Zhang; Chaonan Zheng; Suraj Peri; Kathy Q Cai; Jessica M Y Ng; Tom Curran; Peng Li; Zeng-Jie Yang
Journal:  Clin Cancer Res       Date:  2019-07-12       Impact factor: 12.531

Review 5.  Nanoparticles for imaging and treating brain cancer.

Authors:  Joseph D Meyers; Tennyson Doane; Clemens Burda; James P Basilion
Journal:  Nanomedicine (Lond)       Date:  2013-01       Impact factor: 5.307

6.  Feasibility study of brain tumor delineation using immunolabeled gold nanorods.

Authors:  Kevin Seekell; Spencer Lewis; Christy Wilson; Shuqin Li; Gerald Grant; Adam Wax
Journal:  Biomed Opt Express       Date:  2013-10-01       Impact factor: 3.732

7.  Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy.

Authors:  Stephen W Gilheeney; Ali Saad; Susan Chi; Christopher Turner; Nicole J Ullrich; Liliana Goumnerova; R Michael Scott; Karen Marcus; Leslie Lehman; Umberto De Girolami; Mark W Kieran
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

8.  Invasion suppressor cystatin E/M (CST6): high-level cell type-specific expression in normal brain and epigenetic silencing in gliomas.

Authors:  Jingxin Qiu; Lingbao Ai; Cheppail Ramachandran; Bing Yao; Suhasni Gopalakrishnan; C Robert Fields; Amber L Delmas; Lisa M Dyer; Steven J Melnick; Anthony T Yachnis; Philip H Schwartz; Howard A Fine; Kevin D Brown; Keith D Robertson
Journal:  Lab Invest       Date:  2008-07-07       Impact factor: 5.662

9.  Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy.

Authors:  D A Orringer; Y E Koo; T Chen; R Kopelman; O Sagher; M A Philbert
Journal:  Clin Pharmacol Ther       Date:  2009-02-25       Impact factor: 6.875

Review 10.  Cerebellar lesion studies of cognitive function in children and adolescents - limitations and negative findings.

Authors:  Benedikt Frank; Beate Schoch; Stefanie Richter; Markus Frings; Hans-Otto Karnath; Dagmar Timmann
Journal:  Cerebellum       Date:  2007       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.